Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03698877 · ClinicalTrials.gov registry record
Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease.
A clinical trial, sponsored by The Rogosin Institute.
- Completed
- Registry status
- 79
- Enrollment target
NCT03698877: Completed study, sponsored by The Rogosin Institute.
NCT03698877 is a clinical trial that has completed, run by The Rogosin Institute. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03698877 has completed, sponsored by The Rogosin Institute.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The study is being conducted to determine if the blood test Brain Natriuretic Protein (BNP) can demonstrate the presence of extra fluid in patients with chronic kidney disease treated by hemodialysis. It will also try to determine the blood test Procalcitonin (PCT) can help identify the cause of the fever, specifically if a fever is caused by a bacterial infection. It will also evaluate whether new blood tests in the future (such as DNA, RNA, metabolite, and protein based tests) can be developed to help predict other complications in patients with chronic kidney disease treated by hemodialysis.
Primary Outcome
To establish a procalcitonin (PCT) algorithm to assist in the identification of bacterial infection in patients with fever and chronic kidney disease being treated by hemodialysis, PCT levels will be obtained and compared to blood cultures.
Interventions
- DIAGNOSTIC_TEST Brain Natriuretic Protein (BNP) and Procalcitonin (PCT) blood tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2018-12-26 |
| Est. Completion | 2022-04-30 |
What the finished NCT03698877 record still lists
NCT03698877 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Brain Natriuretic Protein (BNP) and Procalcitonin (PCT) blood tests is the first listed.
NCT03698877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03698877 about?
NCT03698877 is a clinical study titled "Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease.". The study is being conducted to determine if the blood test Brain Natriuretic Protein (BNP) can demonstrate the presence of extra fluid in patients with chronic kidney disease treated by hemodialysis. It will also try to determine the blood test Procalcitonin (PCT) can help identify the cause of the...
What is the current status of trial NCT03698877?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2018-12-26. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT03698877?
The interventions under investigation include: Brain Natriuretic Protein (BNP) and Procalcitonin (PCT) blood tests (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03698877?
This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI